PCSK9 and peripheral arterial disease: In addition, plasma PCSK9 levels were significantly higher in patients with peripheral artery disease, especially those with extensive, severe, and complicated forms of the condition [40], suggesting that PCSK9 functions as a proatherogenic molecule [48].